THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 127 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,794 | -1.8% | 4,727 | +17.7% | 0.00% | 0.0% |
| Q2 2023 | $41,556 | +207680.0% | 4,015 | +116.1% | 0.00% | 0.0% |
| Q1 2023 | $20 | -4.8% | 1,858 | -3.3% | 0.00% | 0.0% |
| Q4 2022 | $21 | -100.0% | 1,922 | -80.5% | 0.00% | -50.0% |
| Q3 2022 | $100,000 | +334.8% | 9,877 | +292.4% | 0.00% | +100.0% |
| Q2 2022 | $23,000 | +53.3% | 2,517 | +64.1% | 0.00% | – |
| Q1 2022 | $15,000 | -21.1% | 1,534 | -12.3% | 0.00% | – |
| Q4 2021 | $19,000 | -26.9% | 1,749 | -50.2% | 0.00% | -100.0% |
| Q3 2021 | $26,000 | -40.9% | 3,509 | +16.0% | 0.00% | 0.0% |
| Q2 2021 | $44,000 | -8.3% | 3,024 | +27.4% | 0.00% | 0.0% |
| Q1 2021 | $48,000 | +92.0% | 2,374 | +65.9% | 0.00% | 0.0% |
| Q4 2020 | $25,000 | -95.3% | 1,431 | -96.1% | 0.00% | -83.3% |
| Q3 2020 | $537,000 | +210.4% | 36,347 | +341.2% | 0.01% | -14.3% |
| Q2 2020 | $173,000 | +116.2% | 8,239 | +166.3% | 0.01% | 0.0% |
| Q4 2019 | $80,000 | +128.6% | 3,094 | +72.1% | 0.01% | +250.0% |
| Q3 2019 | $35,000 | +105.9% | 1,798 | +68.7% | 0.00% | +100.0% |
| Q2 2019 | $17,000 | -32.0% | 1,066 | -0.1% | 0.00% | -50.0% |
| Q1 2019 | $25,000 | +150.0% | 1,067 | +166.8% | 0.00% | +100.0% |
| Q4 2018 | $10,000 | -16.7% | 400 | -23.5% | 0.00% | 0.0% |
| Q2 2018 | $12,000 | -25.0% | 523 | -20.8% | 0.00% | 0.0% |
| Q1 2018 | $16,000 | +6.7% | 660 | +20.9% | 0.00% | -50.0% |
| Q4 2017 | $15,000 | -93.4% | 546 | -91.8% | 0.00% | -89.5% |
| Q3 2017 | $227,000 | +383.0% | 6,654 | +458.7% | 0.02% | +280.0% |
| Q2 2017 | $47,000 | +487.5% | 1,191 | +436.5% | 0.01% | +400.0% |
| Q1 2017 | $8,000 | +166.7% | 222 | +167.5% | 0.00% | – |
| Q4 2016 | $3,000 | -40.0% | 83 | -63.8% | 0.00% | – |
| Q2 2016 | $5,000 | +150.0% | 229 | +84.7% | 0.00% | – |
| Q4 2015 | $2,000 | – | 124 | +1140.0% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 10 | -76.2% | 0.00% | – |
| Q3 2014 | $1,000 | -83.3% | 42 | -75.9% | 0.00% | -100.0% |
| Q2 2014 | $6,000 | – | 174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |